针对被忽视疾病的药物研发创新伙伴关系。 - Suppr

Suppr

超能文献

Innovative partnerships for drug discovery against neglected diseases.

作者信息

Jakobsen Palle H, Wang Ming-Wei, Nwaka Solomon

机构信息

Novo Nordisk A/S, Bagsvaerd, Denmark.

出版信息

PLoS Negl Trop Dis. 2011 Sep;5(9):e1221. doi: 10.1371/journal.pntd.0001221. Epub 2011 Sep 27.

DOI:10.1371/journal.pntd.0001221

PMID:21980540

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3181237/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a22/3181237/b09f0a1c4a96/pntd.0001221.g001.jpg

相似文献

Innovative partnerships for drug discovery against neglected diseases.针对被忽视疾病的药物研发创新伙伴关系。

PLoS Negl Trop Dis. 2011 Sep;5(9):e1221. doi: 10.1371/journal.pntd.0001221. Epub 2011 Sep 27.

Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature.公私伙伴关系是否是解决被忽视热带病的方法？文献系统评价。

Health Policy. 2017 Jul;121(7):745-754. doi: 10.1016/j.healthpol.2017.05.005. Epub 2017 May 19.

Progress in public-private partnerships to fight neglected diseases.公私伙伴关系在防治被忽视疾病方面的进展。

Health Aff (Millwood). 2009 Nov-Dec;28(6):1745-9. doi: 10.1377/hlthaff.28.6.1745.

Drugs for neglected diseases: part II.治疗被忽视疾病的药物：第二部分。

Future Med Chem. 2011 Sep;3(11):1329-30. doi: 10.4155/fmc.11.104.

Ending neglected tropical diseases.终结被忽视的热带病。

Lancet Infect Dis. 2017 Jun;17(6):584-585. doi: 10.1016/S1473-3099(17)30253-0.

Interview with Solomon Nwaka.采访所罗门·恩瓦卡。

Future Med Chem. 2011 Sep;3(11):1339-44. doi: 10.4155/fmc.11.99.

Development assistance for neglected tropical diseases: progress since 2009.针对被忽视热带病的发展援助：2009年以来的进展

Int Health. 2014 Sep;6(3):162-71. doi: 10.1093/inthealth/ihu052. Epub 2014 Aug 5.

Tropical disease: A neglected cause.热带疾病：一个被忽视的病因。

Nature. 2016 May 12;533(7602):S68-9. doi: 10.1038/533S68a.

Neglected tropical disease research: rethinking the drug discovery model.被忽视的热带病研究：重新思考药物研发模式。

Future Med Chem. 2015;7(6):693-700. doi: 10.4155/fmc.15.29.

The importance of patent sharing in neglected disease drug discovery.专利共享在被忽视疾病药物研发中的重要性。

Future Med Chem. 2011 Sep;3(11):1331-4. doi: 10.4155/fmc.11.101.

引用本文的文献

Public-private partnerships influencing the initiation and duration of clinical trials for neglected tropical diseases.公私合作伙伴关系对被忽视热带病临床试验的启动和持续时间的影响。

PLoS Negl Trop Dis. 2023 Nov 13;17(11):e0011760. doi: 10.1371/journal.pntd.0011760. eCollection 2023 Nov.

Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges.消除耐药性疟疾的努力及其面临的挑战。

Biomed Res Int. 2021 Aug 30;2021:5539544. doi: 10.1155/2021/5539544. eCollection 2021.

Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity.肉桂酰基-氧硼杂环戊烷酰胺的合成及其体外生物活性。

Molecules. 2018 Aug 15;23(8):2038. doi: 10.3390/molecules23082038.

Innovation in neglected tropical disease drug discovery and development.被忽视热带病药物研发的创新。

Infect Dis Poverty. 2018 Jun 18;7(1):67. doi: 10.1186/s40249-018-0444-1.

Debates about Conflict of Interest in Medicine: Deconstructing a Divided Discourse.医学领域利益冲突的辩论：剖析一场分歧的论述

J Bioeth Inq. 2017 Mar;14(1):135-149. doi: 10.1007/s11673-016-9764-7. Epub 2017 Jan 3.

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles.开源药物发现：源自特雷斯坎托斯芳基吡咯的高效抗疟化合物。

ACS Cent Sci. 2016 Oct 26;2(10):687-701. doi: 10.1021/acscentsci.6b00086. Epub 2016 Sep 14.

Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.新出现和再出现的被忽视热带病：关键特征、风险因素以及政策与创新环境综述

Clin Microbiol Rev. 2014 Oct;27(4):949-79. doi: 10.1128/CMR.00045-14.

The crisis of capitalism and the marketisation of health care: the implications for public health professionals.资本主义危机与医疗保健市场化：对公共卫生专业人员的影响。

J Public Health Res. 2012 Dec 7;1(3):236-9. doi: 10.4081/jphr.2012.e37. eCollection 2012 Dec 28.

Drug repurposing and human parasitic protozoan diseases.药物再利用与人体寄生原生动物病。

Int J Parasitol Drugs Drug Resist. 2014 Mar 24;4(2):95-111. doi: 10.1016/j.ijpddr.2014.02.002. eCollection 2014 Aug.

New chemical scaffolds for human african trypanosomiasis lead discovery from a screen of tyrosine kinase inhibitor drugs.从酪氨酸激酶抑制剂药物筛选中发现用于治疗人类非洲锥虫病的新型化学骨架。

Antimicrob Agents Chemother. 2014;58(4):2202-10. doi: 10.1128/AAC.01691-13. Epub 2014 Jan 27.

本文引用的文献

Developing ANDI: a novel approach to health product R&D in Africa.开发 ANDI：一种在非洲进行保健品研发的新方法。

PLoS Med. 2010 Jun 29;7(6):e1000293. doi: 10.1371/journal.pmed.1000293.

Peer-to-Peer Sharing Spurs Scientific Innovation.点对点共享促进科学创新。

Sci Transl Med. 2009 Dec 2;1(9):9ed2. doi: 10.1126/scitranslmed.3000584.

A call for sharing: adapting pharmaceutical research to new realities.呼吁共享：使药物研究适应新现实。

Sci Transl Med. 2009 Dec 2;1(9):9cm8. doi: 10.1126/scitranslmed.3000155.

Solutions to neglected tropical diseases require vibrant local scientific communities.解决被忽视的热带病问题需要充满活力的当地科学界。

PLoS Negl Trop Dis. 2010 Mar 30;4(3):e662. doi: 10.1371/journal.pntd.0000662.

Advancing drug innovation for neglected diseases-criteria for lead progression.推进针对被忽视疾病的药物创新——先导化合物进展标准

PLoS Negl Trop Dis. 2009 Aug 25;3(8):e440. doi: 10.1371/journal.pntd.0000440.

The African Network for Drugs and Diagnostics Innovation.非洲药物与诊断创新网络

Lancet. 2009 May 2;373(9674):1507-8. doi: 10.1016/S0140-6736(09)60838-2.

Neglected disease research and development: how much are we really spending?被忽视疾病的研发：我们实际投入了多少？

PLoS Med. 2009 Feb 3;6(2):e30. doi: 10.1371/journal.pmed.1000030.

Mission possible.任务可行。

Nature. 2007 Sep 13;449(7159):166-9. doi: 10.1038/449166a.

The path to new medicines.新药之路。

Nature. 2007 Sep 13;449(7159):164-5. doi: 10.1038/449164a.

Innovative lead discovery strategies for tropical diseases.热带疾病的创新先导化合物发现策略。

Nat Rev Drug Discov. 2006 Nov;5(11):941-55. doi: 10.1038/nrd2144.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验